Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

R&D=Rx for Growth

Article Abstract:

Warner-Lambert Co. is now trying to become known as a health care company. The company has taken steps in this direction by acquiring IMED, a maker of intravenous equipment which is expected to grow rapidly. At the same time Warner-Lambert sold its specialty baked goods unit, Entemann's Incorporated, which confused the company's image. Most important of all was Warner-Lambert's purchase of Parke-Davis, an old-line ethical drug company. Once the FTC cleared the purchase in 1978, Warner-Lambert was able to fully develop Parke-Davis' potential. Several revolutionary new drug products are scheduled for release by Warner-Lambert in 1984, and they were all developed in the laboratories of the former Parke-Davis.

Author: Gibson, W.D.
Publisher: Dow Jones & Company, Inc.
Publication Name: Barron's
Subject: Business, general
ISSN: 1077-8039
Year: 1984

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Flights of Fancy

Article Abstract:

Early space toys are becoming worthy of collection. Many of them are in scarce supply. Toy robots have gained enormously in popularity.

Author: Gibson, W.D.
Publisher: Dow Jones & Company, Inc.
Publication Name: Barron's
Subject: Business, general
ISSN: 1077-8039
Year: 1984

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Hot time for coal. King of the aisles. A setback, but not a calamity
  • Abstracts: Reaching for the Stars. Why Trapshooters Have a Blast. Bass: The Complete Fishing Experience
  • Abstracts: Two Bellwether Races. How US Automakers are Fighting Back. Dollars, Not Censure
  • Abstracts: The Trader. Bull Session. Some Like It Hot
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.